The inhaled Steroid Treatment as Regular Therapy in early Asthma (START) study: Rationale and design

Controlled Clinical Trials

Volumn 22, Issue 4, 2001, Pages 405-419

  Pauwels, Romain A ^a   Busse, William W ^b   O'Byrne, Paul M ^c   Pedersen, Sören ^d   Tan, Wan C ^e   Chen, Yu Zhi ^f   Ohlsson, Stefan V ^g   Ullman, Anders ^g  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^e Singapore University   (Singapore)

^f CAPITAL INSTITUTE OF PEDIATRICS   (China)

^g ASTRAZENECA R AND D   (Sweden)

Author keywords

Asthma; Asthma related events; Bronchial reversibility; Budesonide; Childhood asthma; Effectiveness studies; Inhaled steroids; Lung function; Spirometry; START

Indexed keywords

BRONCHODILATING AGENT; BUDESONIDE; GLUCOCORTICOID;

ADULT; AIRFLOW; AIRWAY OBSTRUCTION; ARTICLE; ASTHMA; BRONCHODILATATION; CHILD; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; METHODOLOGY; RANDOMIZED CONTROLLED TRIAL; SPIROMETRY; STEROID THERAPY; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ACUTE DISEASE; ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; ASTHMA; BUDESONIDE; CHILD; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; MIDDLE AGED; MULTICENTER STUDIES; NEBULIZERS AND VAPORIZERS; OUTCOME ASSESSMENT (HEALTH CARE); RANDOM ALLOCATION; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; RESPIRATORY FUNCTION TESTS; SAMPLE SIZE; STATISTICS;

EID: 0034881557     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(01)00144-1     Document Type: Article

References (48)

1. Identification of activated T lymphocytes and eosinophils in bronchial biopsies in stable atopic asthma
2. Mucosal inflammation in asthma
3. Airway mucosal inflammation even in patients with newly diagnosed asthma
4. Airway responsiveness and bronchial-wall thickness in asthma with or without fixed airflow obstruction
5. Airway wall remodeling in asthma: A novel target for the development of anti-asthma drugs
6. Small airway dimensions in asthma and in chronic obstructive pulmonary disease
7. Comparison of a beta2-agonist, terbutaline with an inhaled corticosteroid, budesonide in newly detected asthma
8. Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma
9. Effects of 22 months of treatment with inhaled corticosteroids and/or beta2-agonists on lung function, airway responsiveness and symptoms in children with asthma
10. A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease
11. Effect of long-term treatment with an inhaled corticosteroid (budesonide) on airway hyperresponsiveness and clinical asthma in nonsteroid-dependent asthmatics
12. Effects of long-term treatment with an inhaled corticosteroid on growth and pulmonary function in asthmatic children
13. Effect of early vs late intervention with inhaled corticosteroid in asthma
14. The British guidelines on asthma management
15. Rate of decline of lung function in subjects with asthma
16. A 15-year follow-up study of ventilatory function in adults with asthma
17. Design and analytical considerations in determining the cost-effectiveness of early intervention in asthma from a multinational clinical trial
18. Efficacy and cost benefit of inhaled corticosteroids in patients considered to have mild asthma in primary care
19. Airway wall remodelling: Does it occur and what does it mean?
20. Physiologic measures: Pulmonary function tests. Asthma outcome
21. Risk factors for the persistence of respiratory symptoms in childhood asthma
22. Adult patients may outgrow their asthma: A 25-year follow-up study
23. Outcome of childhood asthma in mid-adult life
24. Effect of inhaled formoterol and budesonide on exacerbations of asthma
25. Pulmicort Turbohaler once daily as initial prophylactic therapy for asthma
26. Efficacy of once- and twice-daily administration of budesonide via Turbuhaler® as initial therapy in patients with mild persistent asthma
27. Administration of budesonide once daily by means of Turbuhaler to subjects with stable asthma
28. Clinical efficacy of low-dose inhaled budesonide once or twice daily in children with mild asthma not previously treated with steroids
29. A multiple-dosing, placebo-controlled study of budesonide inhalation suspension given once or twice daily for treatment of persistent asthma in young children and infants
30. Once-daily inhaled corticosteroids in children with asthma: Nebulisation
31. Once-daily inhaled corticosteroids in mild to moderate asthma: Improving acceptance of treatment
32. Once-daily budesonide: 400 Microgram once daily is as effective as 200 microgram twice daily in controlling childhood asthma
33. Efficacy of once-daily versus twice-daily administration of budesonide by Turbuhaler® in children with stable asthma
34. Once-daily budesonide inhalation suspension for the treatment of persistent asthma in infants and young children
35. A comparison of the effects of bid and qid dosing on compliance with inhaled flunisolide
36. Measuring compliance with inhaled medication in asthma
37. Measuring efficacy and safety of different inhaled corticosteroid preparations
38. A comparison of the efficacy and safety of inhaled corticosteroids in asthma
39. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma
40. Bone mineral density in children with asthma receiving long-term treatment with inhaled budesonide
41. Use of inhaled corticosteroids and the risk of cataracts
42. Association of inhaled corticosteroid use with cataract extraction in elderly patients
43. Absence of posterior subcapsular cataracts in young patients treated with inhaled glucocorticoids
44. Posterior subcapsular cataract and inhaled corticosteroid therapy
45. Posterior subcapsular cataracts, bruises and hoarseness in children with asthma receiving long-term treatment with inhaled budesonide
46. Congenital malformations after the use of inhaled budesonide in early pregnancy